Correlation Between MOLSON RS and Atossa Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MOLSON RS and Atossa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MOLSON RS and Atossa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MOLSON RS BEVERAGE and Atossa Therapeutics, you can compare the effects of market volatilities on MOLSON RS and Atossa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MOLSON RS with a short position of Atossa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MOLSON RS and Atossa Therapeutics.

Diversification Opportunities for MOLSON RS and Atossa Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between MOLSON and Atossa is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding MOLSON RS BEVERAGE and Atossa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atossa Therapeutics and MOLSON RS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MOLSON RS BEVERAGE are associated (or correlated) with Atossa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atossa Therapeutics has no effect on the direction of MOLSON RS i.e., MOLSON RS and Atossa Therapeutics go up and down completely randomly.

Pair Corralation between MOLSON RS and Atossa Therapeutics

Assuming the 90 days trading horizon MOLSON RS BEVERAGE is expected to under-perform the Atossa Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, MOLSON RS BEVERAGE is 1.9 times less risky than Atossa Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Atossa Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  53.00  in Atossa Therapeutics on September 12, 2024 and sell it today you would earn a total of  64.00  from holding Atossa Therapeutics or generate 120.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

MOLSON RS BEVERAGE  vs.  Atossa Therapeutics

 Performance 
       Timeline  
MOLSON RS BEVERAGE 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MOLSON RS BEVERAGE are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, MOLSON RS may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Atossa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Atossa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

MOLSON RS and Atossa Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MOLSON RS and Atossa Therapeutics

The main advantage of trading using opposite MOLSON RS and Atossa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MOLSON RS position performs unexpectedly, Atossa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Therapeutics will offset losses from the drop in Atossa Therapeutics' long position.
The idea behind MOLSON RS BEVERAGE and Atossa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals